PHARMACEUTICAL OPPORTUNITIES
Pharmaceutical Opportunities
Tech-9094c: Licensing Opportunity: RNA Inhibitors for Cancer Treatment
This technology, offered for licensing, provides a novel and potentially non-toxic approach to treat a wide range of cancers using RNA Inhibitors.
Tech-2520: Clinically Tried and Proven Herbal Cream for Dry Skin
Available for Licensing or Sale. Developed by a doctor with extensive experience in treating patients with eczema, psoriasis, and dry, itchy or infected skin.
Tech-2518: Granulocyte Therapy for Cancer Cure
Granulocyte Therapy for Cancer Cure is available of licensing / collaboration. 100% successful in mice
Tech-9094b: Versatile PEG Nanoparticles for Drug Delivery
These biocompatible, non-toxic nanospheres are 20-80 nm in size and due to their hydrophilc-hydrophobic nature, are ideally suited for encapsulating drugs.
Tech-9094a: Licensing Opportunity: Endotoxin-binding Compounds for Sepsis (Orphan Drug Approval Pending)
The company is likely to get an Orphan Drug Approval in Jan, 2020 for these unique molecules that provide effective treatment for sepsis (for which currently there is no treatment. A unique opportunity...